| |
| |
|
| Insider
Information: |
Fuglesang Christopher |
| Relationship: |
Director, 10% Owner |
| City: |
Solana Beach |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
3,201,440 |
|
|
Indirect Shares
|
3,183,483 |
|
|
| Direct
Value |
$187,924,528 |
|
|
|
Indirect Value
|
$186,870,452 |
|
|
| Total
Shares |
6,384,923 |
|
|
| Total
Value |
$374,794,980 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
2
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-2.0
|
| Percentage
Gain/Loss : |
 51.3%
|
 -53.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirati Therapeutics, Inc. |
MRTX |
|
2023-08-11 |
3,201,440 |
2023-08-11 |
3,183,483 |
Premium* |
|
|
Pandion Therapeutics, Inc. |
PAND |
Director, 10% Owner |
2020-07-21 |
0 |
2021-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRTX |
Mirati Therapeutics, Inc. |
See remarks |
• • – |
2023-08-11 |
4 |
B |
$27.80 |
$33,400,032 |
D/D |
1,201,440 |
3,201,440 |
0.01 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
See remarks |
• • – |
2023-08-11 |
4 |
B |
$27.80 |
$1,599,417 |
I/I |
57,533 |
287,866 |
0.01 |
% |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2021-04-01 |
4 |
D |
$60.00 |
$127,868,100 |
I/I |
(2,131,135) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2021-03-05 |
4 |
S |
$181.00 |
$72,460,905 |
D/D |
(400,005) |
2,000,000 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2021-03-05 |
4 |
OE |
$0.00 |
$611 |
D/D |
611,440 |
2,363,004 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2020-10-30 |
4 |
D |
$219.97 |
$660 |
D/D |
(3) |
1,765,560 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2020-10-30 |
4 |
OE |
$0.00 |
$400 |
D/D |
400,003 |
1,765,562 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2020-10-30 |
4 |
S |
$202.00 |
$80,800,000 |
D/D |
(400,000) |
1,404,610 |
0 |
% |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$12,999,996 |
I/I |
722,222 |
2,600,773 |
2.25 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,408,913 |
1,408,913 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2017-01-06 |
4 |
B |
$5.60 |
$1,602,513 |
D/D |
286,163 |
435,444 |
2.45 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
